NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
NCT06066437
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Arm A: 177Lu rhPSMA-10.1
DRUG:
Arm B: 177Lu rhPSMA-10.1 plus Degarelix
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]